Santen Pharmaceutical Co., Ltd. is a prominent pharmaceutical company focusing on ophthalmology. Established in 1890 and headquartered in Osaka, Japan, Santen specializes in the research, development,... Santen Pharmaceutical Co., Ltd. is a prominent pharmaceutical company focusing on ophthalmology. Established in 1890 and headquartered in Osaka, Japan, Santen specializes in the research, development, and manufacturing of innovative eye care products. The company's portfolio includes a wide range of treatments for a variety of ophthalmic conditions such as glaucoma, dry eye, and retinal diseases. Santen has a strong emphasis on R&D to deliver advanced therapies and improve the quality of life for patients worldwide. Alongside traditional pharmaceutical products, the company also explores new areas such as digital ophthalmic solutions and regenerative medicine. Santen Pharmaceutical Co., Ltd. serves a global market, maintaining a significant presence in Europe and Asia, with a growing influence in North America. Its commitment to eye health, alongside strategic partnerships and a robust pipeline, position the company as a leader in the ophthalmology sector, contributing significantly to advancements in the treatment of eye diseases.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Santen Pharmaceutical is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Santen Pharmaceutical is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Santen Pharmaceutical's data?

Create a free Tracenable account to signal interest in having our team review data for Santen Pharmaceutical.

Legal Center Contact Us